Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
David N. Krag;Stewart J. Anderson;Thomas B. Julian;Ann M. Brown.
Lancet Oncology (2010)
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation
Bernard Fisher;Jong-Hyeon Jeong;Stewart Anderson;John Bryant.
The New England Journal of Medicine (2002)
The Effect on Tumor Response of Adding Sequential Preoperative Docetaxel to Preoperative Doxorubicin and Cyclophosphamide: Preliminary Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
Harry D. Bear;Stewart Anderson;Ann Brown;Roy Smith.
Journal of Clinical Oncology (2003)
Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.
Bernard Fisher;Norman Wolmark;Howard Rockette;Carol Redmond.
Journal of the National Cancer Institute (1988)
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
Bernard Fisher;James Dignam;Norman Wolmark;D Lawrence Wickerham.
The Lancet (1999)
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial
David N Krag;Stewart J Anderson;Thomas B Julian;Ann M Brown.
Lancet Oncology (2007)
Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast Cancer
B Fisher;J Costantino;C Redmond;E Fisher.
The New England Journal of Medicine (1993)
Five Versus More Than Five Years of Tamoxifen Therapy for Breast Cancer Patients With Negative Lymph Nodes and Estrogen Receptor-Positive Tumors
Bernard Fisher;James Dignam;John Bryant;Arthur DeCillis.
Journal of the National Cancer Institute (1996)
Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.
B. Fisher;J. Dignam;N. Wolmark;E. Mamounas.
Journal of Clinical Oncology (1998)
Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2-Overexpressing Breast Cancer: NSABP B-31
Elizabeth Tan-Chiu;Greg Yothers;Edward Romond;Charles E. Geyer.
Journal of Clinical Oncology (2005)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: